Cited by 3,162Lipoproteins and Cardiovascular HealthCardiovascular Health and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Open access

Gordon, D J, Probstfield, J L, Garrison, R J, Neaton, J D, Castelli, W P, Knoke, J D, Jacobs, D R, Bangdiwala, S, Tyroler, H A·1989·Circulation

DOI 10.1161/01.cir.79.1.8

Open this paper in CoChat — free account Open PDF

Abstract

The British Regional Heart Study (BRHS) reported in 1986 that much of the inverse relation of high-density lipoprotein cholesterol (HDLC) and incidence of coronary heart disease was eliminated by covariance adjustment. Using the proportional hazards model and adjusting for age, blood pressure, smoking, body mass index, and low-density lipoprotein cholesterol, we analyzed this relation separately in the Framingham Heart Study (FHS), Lipid Research Clinics Prevalence Mortality Follow-up Study (LRCF) and Coronary Primary Prevention Trial (CPPT), and Multiple Risk Factor Intervention Trial (MRFIT). In CPPT and MRFIT (both randomized trials in middle-age high-risk men), only the control groups were analyzed. A 1-mg/dl (0.026 mM) increment in HDLC was associated with a significant coronary heart disease risk decrement of 2% in men (FHS, CPPT, and MRFIT) and 3% in women (FHS). In LRCF, where only fatal outcomes were documented, a 1-mg/dl increment in HDLC was associated with significant 3.7% (men) and 4.7% (women) decrements in cardiovascular disease mortality rates. The 95% confidence intervals for these decrements in coronary heart and cardiovascular disease risk in the four studies overlapped considerably, and all contained the range 1.9-2.9%. HDLC levels were essentially unrelated to non-cardiovascular disease mortality. When differences in analytic methodology were eliminated, a consistent inverse relation of HDLC levels and coronary heart disease event rates was apparent in BRHS as well as in the four American studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.79.1.8

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Self-citation
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
A SIMPLIFIED METHOD FOR THE ESTIMATION OF TOTAL CHOLESTEROL IN SERUM AND DEMONSTRATION OF ITS SPECIFICITY
Abell, L. L., Levy, B. B., Brodie, B. B., & Kendall, F. E. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50907-3 · Cited by 3,085
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Self-citation
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts
Blankenhorn, D. H. (1987) · JAMA · doi:10.1001/jama.1987.03390230069027 · Cited by 1,654
High density lipoprotein metabolism.
Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,212

Flagged first, then by citations

Show all 27 references

Research works printed but not linked: 8

Miller NE, Forde OH, Thelle DS, Mjos OD: The Tromso Heart Study: High-density lipoprotein and coronary heart disease: A prospective case-control study. Lancet 1977; 1:965-970
Gordon DJ, Knoke J, Probstfield JL, Superko R, Tyroler HA (for the Lipid Research Clinics Program): High-density lipoprotein cholesterol and coronary heart disease in hyper- cholesterolemic men: The Lipid Research Clinics Coronary Primary Prevention Trial. Circulation 1986;74:1217-1225
The Lipid Research Clinics Program Epidemiology Commit- tee: Plasma Lipid Distribution in Selected North American Populations: The Lipid Research Clinics Program Preva- lence Study. Circulation 1979;60:427-439
The Lipid Research Clinics Program: The Coronary Primary Prevention Trial: Design and implementation. J Chronic Dis 1979;32:609-631
The Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduc- tion in incidence of coronary heart disease. JA1M 1984; 251:351-364
The Multiple Risk Factor Intervention Trial Group: Statisti- cal design considerations in the NHLBI Multiple Risk Fac- tor Intervention Trial (MRFIT). J Chronic Dis 1977; 30:261-275
Multiple Risk Factor Intervention Trial Research Group: Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results. JAMA 1982;248:1465-1477
Shestov DB: Results of four years of follow-up of USSR populations, in USA-USSR First Lipoprotein Symposium. US Department of Health and Human Services Publication (NIH) 83-1966, Bethesda, Md, 1982, pp 391-407

Sorted by citations

Items 501–600 of 1,007

Can Millet Consumption Help Manage Hyperlipidemia and Obesity?: A Systematic Review and Meta-Analysis
Anitha, S., Botha, R., Kane‐Potaka, J., Givens, D. I., Rajendran, A., Tsusaka, T. W., & Bhandari, R. K. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.700778 · Cited by 84
High-Density Lipoprotein Cholesterol and Coronary Heart Disease
Young, C. E., Karas, R. H., & Kuvin, J. T. (2004) · Cardiology in Review · doi:10.1097/01.crd.0000097140.29929.8a · Cited by 84
Sex differences and the effects of sex hormones on hemostasis and vascular reactivity
Schwertz, D. W., & Penckofer, S. M. (2001) · Heart & Lung · doi:10.1067/mhl.2001.118764 · Cited by 83
Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol.
Kopfler, W. P., Willard, M., Betz, T., Willard, J. E., Gerard, R. D., & Meidell, R. S. (1994) · Circulation · doi:10.1161/01.cir.90.3.1319 · Cited by 84
Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia.
Katzel, L. I., Coon, P. J., Busby‐Whitehead, M. J., Gottlieb, S. O., Krauss, R. M., & Goldberg, A. P. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.7.814 · Cited by 84
The safety of HMG-CoA reductase inhibitors in special populations at high cardiovascular risk
Corsini, A. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1026132412074 · Cited by 82
Nascent HDL formation in hepatocytes and role of ABCA1, ABCG1, and SR-BI
Ji, A., Wroblewski, J. M., Cai, L., de Beer, M. C., Webb, N. R., & van der Westhuyzen, D. R. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m017079 · Cited by 89
Fatty acid saturation of the diet and plasma lipid concentrations, lipoprotein particle concentrations, and cholesterol efflux capacity
Montoya, M. T., Porres, A., Serrano, S., Fruchart, J., Mata, P., Gerique, J. A. G., & Castro, G. R. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.3.484 · Cited by 83
Fibrate Therapy
Remick, J. S., WEINTRAUB, H. S., Setton, R. A., Offenbacher, J., Fisher, E. A. A., & Schwartzbard, A. Z. (2008) · Cardiology in Review · doi:10.1097/crd.0b013e31816b43d3 · Cited by 83
Effect of HDL-Raising Drugs on Cardiovascular Outcomes: A Systematic Review and Meta-Regression
Kaur, N., Pandey, A. K., Negi, H., Shafiq, N., Reddy, S., Kaur, H., Chadha, N., & Malhotra, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094585 · Cited by 83
Hematopoietic Stem/Progenitor Cell Proliferation and Differentiation Is Differentially Regulated by High-Density and Low-Density Lipoproteins in Mice
Feng, Y., Schouteden, S., Geenens, R., Duppen, V. V., Herijgers, P., Holvoet, P., Veldhoven, P. P. V., & Verfaillie, C. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047286 · Cited by 87
The Role of High-Density Lipoproteins in Reducing the Risk of Vascular Diseases, Neurogenerative Disorders, and Cancer
McGrowder, D. A., Riley, C. K., Morrison, E., & Gordon, L. (2010) · Cholesterol · doi:10.1155/2011/496925 · Cited by 85
Design & Rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
Downs, J. R., Beere, P. A., Whitney, E. J., Clearfield, M. B., Weis, S. E., Rochen, J., Stein, E. A., Shapiro, D. R., Langendörfer, A., & Gotto, A. M. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00347-0 · Cited by 83
Anti-inflammatory effects of apolipoprotein A-I in the rabbit
Patel, S., Bartolo, B. A. D., Nakhla, S., Heather, A. K., Mitchell, T. W., Jessup, W., Celermajer, D. S., Barter, P. J., & Rye, K.-A. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.035 · Cited by 82
Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence
Preiss, D., & Sattar, N. A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03490.x · Cited by 80
One-Year Effects of Increasingly Fat-Restricted, Carbohydrate-Enriched Diets on Lipoprotein Levels in Free-Living Subjects
Knopp, R. H., Retzlaff, B. M., Walden, C. E., Fish, B. E., Buck, B. L., & McCann, B. S. (2000) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22524.x · Cited by 82
Tracking of serum HDL-cholesterol and other lipids in children and adolescents: The cardiovascular risk in young finns study
Porkka, K., Viikari, J. S. A., & Åkerblom, H. K. (1991) · Preventive Medicine · doi:10.1016/0091-7435(91)90066-d · Cited by 82
High Density Lipoprotein (HDL) Reduces Renal Ischemia/Reperfusion Injury
Thiemermann, C., Patel, N. S. A., Kvale, E. Ø., COCKERILL, G. W., Brown, P. A., Stewart, K. N., Cuzzocrea, S., Britti, D., Mota‐Filipe, H., & Chatterjee, P. K. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000075552.97794.8c · Cited by 83
Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights
Das, M., & Gursky, O. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17344-3_8 · Cited by 80
Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis
Akioyamen, L. E., Genest, J. J., Chu, A., Inibhunu, H., Ko, D. T., & Tu, J. V. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.10.012 · Cited by 86
The Extracellular Protein, Transthyretin Is an Oxidative Stress Biomarker
Sharma, M., Khan, S., Rahman, S., & Singh, L. R. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00005 · Cited by 80
Effects of zinc on plasma lipoprotein cholesterol concentrations in humans: A meta-analysis of randomised controlled trials
Foster, M. J., Petocz, P., & Samman, S. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.11.038 · Cited by 80
Role of HDL Dysfunction in End-Stage Renal Disease: A Double-Edged Sword
Moradi, H., Vaziri, N. D., Kashyap, M. L., Said, H. M., & Kalantar‐Zadeh, K. (2013) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2013.01.022 · Cited by 81
Relationship of Plasma Cholesteryl Ester Transfer Protein to HDL Cholesterol
Föger, B., Ritsch, A., Doblinger, A., Wessels, H., & Patsch, J. R. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.12.1430 · Cited by 81
Icariin Attenuates High-cholesterol Diet Induced Atherosclerosis in Rats by Inhibition of Inflammatory Response and p38 MAPK Signaling Pathway
Hu, Y., Sun, B., Liu, K., Yan, M., Zhang, Y., Miao, C., & Ren, L. (2015) · Inflammation · doi:10.1007/s10753-015-0242-x · Cited by 80
Blood lipids among young children in Europe: results from the European IDEFICS study
Henauw, S. D., Michels, N., Vyncke, K. E., Hebestreit, A., Russo, P., Intemann, T., Peplies, J., Fraterman, A., Eiben, G., de Lorgeril, M., et al. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.137 · Cited by 80
Long-Term Renal Function and Cardiovascular Disease Risk in Obese Kidney Donors
Tavakol, M. M., Vincenti, F. G., Assadi, H. R., Frederick, M. J., Tomlanovich, S. J., Roberts, J. P., & Posselt, A. M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01350209 · Cited by 80
ABCA1 Overexpression in the Liver of LDLr-KO Mice Leads to Accumulation of Pro-atherogenic Lipoproteins and Enhanced Atherosclerosis
Joyce, C. W., Wagner, E. M., Basso, F., Amar, M. J., Freeman, L. A., Shamburek, R. D., Knapper, C. L., Syed, J., Wu, J., Vaisman, B. L., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604526200 · Cited by 80
Time-dependent effects of safflower oil to improve glycemia, inflammation and blood lipids in obese, post-menopausal women with type 2 diabetes: A randomized, double-masked, crossover study
Asp, M. L., Collene, A. L., Norris, L. E., Cole, R. M., Stout, M. B., Tang, S.-Y., Hsu, J. C., & Belury, M. A. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.01.001 · Cited by 82
Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice
de Haan, W., van der Hoogt, C. C., Westerterp, M., Hoekstra, M., Dallinga‐Thie, G. M., Princen, H. M. G., Romijn, J. A., Jukema, J. W., Havekes, L. M., & Rensen, P. C. N. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.08.001 · Cited by 82
Moderate to High Concentrations of High-Density Lipoprotein From Healthy Subjects Paradoxically Impair Human Endothelial Progenitor Cells and Related Angiogenesis by Activating Rho-Associated Kinase Pathways
Huang, C., Lin, F., Shih, C., Au, H., Chang, Y., Nakagami, H., Morishita, R., Chang, N., Shyu, K., & Chen, J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.248617 · Cited by 80
Guidelines on the management of stable angina pectoris
Skalidis, E. I., & Vardas, P. E. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl257 · Cited by 80
HDL Cholesterol: Physiology, Pathophysiology, and Management
Link, J. J., Rohatgi, A. K., & de Lemos, J. A. (2007) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2007.01.004 · Cited by 81
High-Density Lipoprotein Metabolism: Potential Therapeutic Targets
Davidson, M. H., & Toth, P. P. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.08.011 · Cited by 79
Paraoxonase Activity Is Reduced by a Pro-atherosclerotic Diet in Rabbits
Mackness, M., Bouiller, A., Hennuyer, N., Mackness, B., Hall, M., Tailleux, A., Duriez, P., Delfly, B., Durrington, P. N., Fruchart, J., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2265 · Cited by 79
Plasma Cholesteryl Ester Transfer Is a Determinant of Intima-Media Thickness in Type 2 Diabetic and Nondiabetic Subjects
de Vries, R., Perton, F. G., Dallinga‐Thie, G. M., van Roon, A. M., Wolffenbuttel, B. H. R., van Tol, A., & Dullaart, R. P. F. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3554 · Cited by 79
High-Density Lipoproteins in the Prevention of Cardiovascular Disease: Changing the Paradigm
Tuteja, S., & Rader, D. J. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.79 · Cited by 77
Regression of Inflammation in Atherosclerosis by the LXR Agonist R211945
Vucic, E., Calcagno, C., Dickson, S. D., Rudd, J. H. F., Hayashi, K., Bucerius, J. A., Moshier, E. L., Mounessa, J. S., Roytman, M., Moon, M. J., et al. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.11.025 · Cited by 78
Influence of acute exercise with and without carbohydrate replacement on postprandial lipid metabolism.
Harrison, M., O'Gorman, D., Mccaffrey, N., Hamilton, M., Zderic, T., Carson, B., & Moyna, N. (2009) · Journal of applied physiology · doi:10.1152/japplphysiol.91367.2008 · Cited by 92
Hepatic origin of cholesteryl oleate in coronary artery atherosclerosis in African green monkeys. Enrichment by dietary monounsaturated fat.
Rudel, L. L., Haines, J., Sawyer, J. K., Shah, R., Wilson, M. S., & Carr, T. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119524 · Cited by 78
Low HDL-C: A secondary target of dyslipidemia therapy
Rosenson, R. S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.12.021 · Cited by 81
Dietary capsanthin, the main carotenoid in paprika (Capsicum annuum), alters plasma high-density lipoprotein-cholesterol levels and hepatic gene expression in rats
Aizawa, K., & Inakuma, T. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509991309 · Cited by 76
GPR109A and Vascular Inflammation
Chai, J. T., Digby, J. E., & Choudhury, R. P. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0325-9 · Cited by 78
The effect of physical exercise on reverse cholesterol transport
Leaf, D. A. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00147-1 · Cited by 76
Human ApoA-I Transfer Attenuates Transplant Arteriosclerosis via Enhanced Incorporation of Bone marrow–derived Endothelial Progenitor Cells
Feng, Y., Jacobs, F., Craeyveld, E. V., Brunaud, C., Snoeys, J., Tjwa, M., Linthout, S. V., & Geest, B. D. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.158741 · Cited by 77
Effects of Alcohol Consumption on Lipoproteins of Premenopausal Women
Clevidence, B. A., Reichman, M. E., Judd, J. T., Muesing, R. A., Schatzkin, A. G., Schaefer, E. J., Li, Z., Jenner, J. L., Brown, C., Sunkin, M. E., et al. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.2.179 · Cited by 77
Efficacy and safety of pravastatin in patients with primary hypercholesterolemia
Hunninghake, D. B., Knopp, R. H., Schonfeld, G., Goldberg, A. C., Brown, W. V., Schaefer, E. J., Margolis, S., Dobs, A. S., Mellies, M. J., Insull, W., et al. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90185-l · Cited by 77
Testosterone enanthate at a dose of 200 mg/week decreases HDL‐cholesterol levels in healthy men
Meriggiola, M. C., Marcovina, S. M., Paulsen, C. A., & Bremner, W. J. (1995) · International Journal of Andrology · doi:10.1111/ijan.1995.18.5.237 · Cited by 77
High-density lipoprotein subfractions and risk of coronary artery disease
Morgan, J., Carey, C., Lincoff, A., & Capuzzi, D. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0047-0 · Cited by 75
Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity
Ooi, E. M. M., Watts, G. F., Sprecher, D. L., Chan, D. C., & Barrett, P. H. R. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1131 · Cited by 77
Exploring the impact of bariatric surgery on high density lipoprotein
Aminian, A., Zelisko, A., Kirwan, J. P., Brethauer, S. A., & Schauer, P. R. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.07.017 · Cited by 80
Racial/Ethnic Differences in the Association of Triglycerides with Other Metabolic Syndrome Components: The Multi-Ethnic Study of Atherosclerosis
Lin, S. X., Carnethon, M. R., Szklo, M., & Bertoni, A. G. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0050 · Cited by 76
HDL-cholesterol in coronary artery disease risk: Function or structure?
Pérez-Méndez, O. A., González‐Pacheco, H., Martínez‐Sánchez, C., & Franco, M. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.12.001 · Cited by 80
The influence of age on the association between cholesterol and cognitive function
van Vliet, P., van de Water, W., de Craen, A. J. M., & Westendorp, R. G. J. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.05.004 · Cited by 82
Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group.
Connelly, P. W., MacLean, D. R., Horlick, L., O'Connor, B., Petrasovits, A., & Little, J. A. (1992) · Europe PMC (PubMed Central) · Cited by 76
Effects of varying dietary fat, fish, and fish oils on blood lipids in a randomized controlled trial in men at risk of heart disease
Mori, T. A., Vandongen, R., Beilin, L. J., Burke, V., Morris, J., & Ritchie, J. (1994) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.5.1060 · Cited by 76
Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study
Manninen, V., Huttunen, J. K., Heinonen, O. P., Tenkanen, L., & Frick, M. H. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90115-x · Cited by 76
Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease
Romm, P. A., Green, C. E., Reagan, K., & Rackley, C. E. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90007-8 · Cited by 75
Pleiotropic Genetic Effects on LDL Size, Plasma Triglyceride, and HDL Cholesterol in Families
Edwards, K. L., Mahaney, M. C., Motulsky, A. G., & Austin, M. A. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.10.2456 · Cited by 75
A Comparison of Estrogen Replacement, Pravastatin, and Combined Treatment for the Management of Hypercholesterolemia in Postmenopausal Women
Davidson, M. H. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.11.1186 · Cited by 75
2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 81
Tyrosine Modification Is Not Required for Myeloperoxidase-induced Loss of Apolipoprotein A-I Functional Activities
Peng, D.-Q., Wu, Z., Brubaker, G., Zheng, L., Settle, M., Gross, E. Z., Kinter, M. T., Hazen, S. L., & Smith, J. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504092200 · Cited by 74
Commuting physical activity is favourably associated with biological risk factors for cardiovascular disease
Smith, L. V. H., Borch‐Johnsen, K., & Jørgensen, T. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9177-3 · Cited by 73
Trans-10, cis-12- and cis-9, trans-11-Conjugated Linoleic Acid Isomers Selectively Modify HDL-Apolipoprotein Composition in Apolipoprotein E Knockout Mice
Arbonés-Mainar, J. M., Navarro, M. Á., Acı́n, S., Guzmán, M., Arnal, C., Surra, J. C., Carnicer, R., Roche, H. M., & Osada, J. (2006) · Journal of Nutrition · doi:10.1093/jn/136.2.353 · Cited by 73
Monensin and Brefeldin A Inhibit High Density Lipoprotein- mediated Cholesterol Efflux from Cholesterol-enriched Cells
Mendez, A. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.5891 · Cited by 74
Arginine-directed glycation and decreased HDL plasma concentration and functionality
Godfrey, L., Yamada-Fowler, N., Smith, J., Thornalley, P. J., & Rabbani, N. (2014) · Nutrition and Diabetes · doi:10.1038/nutd.2014.31 · Cited by 74
The Antioxidant Function of High Density Lipoproteins: A New Paradigm in Atherosclerosis
Tomás, M., Latorre, G. N., Sentı́, M., & Marrugat, J. (2004) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60630-0 · Cited by 73
Plasma Lipid and Lipoprotein Levels during the Follicular and Luteal Phases of the Menstrual Cycle
Barnett, J. B., Woods, M. N., Lamon‐Fava, S., Schaefer, E. J., McNamara, J. R., Spiegelman, D. L., Hertzmark, E., Goldin, B. R., Longcope, C., & Gorbach, S. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030506 · Cited by 73
HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects
Berglund, L., Oliver, E. H., Fontanez, N., Holleran, S., Matthews, K. A., Roheim, P. S., Ginsberg, H. N., Ramakrishnan, R., & LeFevre, M. L. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.6.992 · Cited by 71
Is There Any Hope for Vitamin E?
Brown, B. (2005) · JAMA · doi:10.1001/jama.293.11.1387 · Cited by 73
Reconstituted High-density Lipoprotein Therapy Improves Survival in Mouse Models of Sepsis
Tanaka, S., Genève, C., Zappella, N., Yong-Sang, J., Planesse, C., Louedec, L., Viranaïcken, W., Bringart, M., Montravers, P., Denamur, É., et al. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003155 · Cited by 75
HDL Cholesterol and Non-Cardiovascular Disease: A Narrative Review
Kjeldsen, E. W., Nordestgaard, L. T., & Frikke‐Schmidt, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094547 · Cited by 76
Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties
Wool, G. D., Reardon, C. A., & Getz, G. S. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700552-jlr200 · Cited by 72
Comparative assessment of lipid effects of endocrine therapy for breast cancer: Implications for cardiovascular disease prevention in postmenopausal women
Esteva, F. J., & Hortobágyi, G. N. (2005) · The Breast · doi:10.1016/j.breast.2005.08.033 · Cited by 74
Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: Results of the Comparative HDL Efficacy and Safety Study (CHESS)
Ballantyne, C. M., Blazing, M. A., Hunninghake, D. B., Davidson, M. H., Yuan, Ž., DeLucca, P. T., Ramsey, K. E., Hustad, C. M., & Palmisano, J. J. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00440-x · Cited by 72
Vitamin D Intake and Status Are Associated with Lower Prevalence of Metabolic Syndrome in U.S. Adults: National Health and Nutrition Examination Surveys 2003–2006
Maki, K. C., Fulgoni, V. L. I., Keast, D. R., Rains, T. M., Park, K. M., & Rubin, M. R. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0020 · Cited by 72
Functional LCAT is not required for macrophage cholesterol efflux to human serum
Calabresi, L., Favari, E., Moleri, E., Adorni, M. P., Pedrelli, M., Costa, S., Jessup, W., Gelissen, I. C., Kovanen, P. T., Bernini, F., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.038 · Cited by 73
Effect of Niacin Therapy on Cardiovascular Outcomes in Patients With Coronary Artery Disease
Duggal, J., Singh, M., Attri, N., Singh, P. P., Ahmed, N., Pahwa, S., Molnár, J., Singh, S., Khosla, S., & Arora, R. R. (2010) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248410361337 · Cited by 71
Are Serum Lipids Involved in Primary Frozen Shoulder?
Sung, C., Jung, T. S., & Park, H. B. (2014) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.m.00936 · Cited by 72
Relation Between Optimism and Lipids in Midlife
Boehm, J. K., Williams, D. R., Rimm, E. B., Ryff, C. D., & Kubzansky, L. D. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.292 · Cited by 76
Comparison of demography, diet, lifestyle, and serum lipid levels between the Guangxi Bai Ku Yao and Han populations
Ruixing, Y., Qiming, F., Dezhai, Y., Li, S., Weixiong, L., Shangling, P., Wu, H., Yongzhong, Y., Feng, H., & Shuming, Q. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700335-jlr200 · Cited by 72
Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease
Peloso, G. M., Demissie, S., Collins, D. E., Mirel, D. B., Gabriel, S., Cupples, L. A., Robins, S. J., Schaefer, E. J., & Brousseau, M. E. (2010) · Journal of Lipid Research · doi:10.1194/jlr.p008268 · Cited by 71
Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL
Matthan, N. R., Giovanni, A., Schaefer, E. J., Brown, B. G., & Lichtenstein, A. H. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200439-jlr200 · Cited by 70
Triglyceride-rich lipoproteins and atherosclerosis
Patsch, J. R. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)05372-p · Cited by 72
Leisure Time Exercise and Lipid and Lipoprotein Levels in an Older Population
Reaven, P. D., McPhillips, J. B., Barrett-Connor, E. L., & Criqui, M. H. (1990) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1990.tb05698.x · Cited by 72
Familial hypercholesterolemia: current treatment and advances in management
Huijgen, R., Vissers, M. N., Defesche, J. C., Lansberg, P. J., Kastelein, J. J. P., & Hutten, B. A. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.4.567 · Cited by 71
Assessing the Functional Properties of High-Density Lipoproteins: An Emerging Concept in Cardiovascular Research
Triolo, M., Annema, W., Dullaart, R. P. F., & Tietge, U. J. F. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.35 · Cited by 71
Efficacy and safety of mipomersen in treatment of dyslipidemia: A meta-analysis of randomized controlled trials
Panta, R., Dahal, K. B., & Kunwar, S. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.12.006 · Cited by 71
High-density lipoprotein cholesterol in diabetes: Is higher always better?
Costacou, T., Evans, R. G., & Orchard, T. J. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.06.011 · Cited by 71
Atheroprotective effects of conjugated linoleic acid
Bruen, R., Fitzsimons, S., & Belton, O. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12948 · Cited by 71
Projecting the future size and health status of the US elderly population
Mantón, K. G., Stallard, E., & Singer, B. (1992) · International Journal of Forecasting · doi:10.1016/0169-2070(92)90057-g · Cited by 71
A randomized, double-blind, placebo-controlled, pilot study to evaluate the effect of whole grape extract on antioxidant status and lipid profile
Evans, M., Wilson, D., & Guthrie, N. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2013.12.017 · Cited by 70
Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets
Martín-Ventura, J. L., Rodrigues‐Díez, R., Martínez-López, D., Salaíces, M., Blanco‐Colio, L. M., & Briones, A. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112315 · Cited by 71
The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol
The AIM-HIGH Investigators (2011) · American Heart Journal · doi:10.1016/j.ahj.2010.11.017 · Cited by 72
Effects of different forms of hazelnuts on blood lipids and α-tocopherol concentrations in mildly hypercholesterolemic individuals
Tey, S. L., Brown, R. C., Chisholm, A. W., Delahunty, C. M., Gray, A. R., & Williams, S. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.200 · Cited by 69
Elucidation of mechanisms of actions of thymoquinone-enriched methanolic and volatile oil extracts from Nigella sativa against cardiovascular risk parameters in experimental hyperlipidemia
Ahmad, S., & Beg, Z. H. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-86 · Cited by 70
Prospective Association between Diabetic Retinopathy and Cardiovascular Disease—A Systematic Review and Meta-analysis of Cohort Studies
Guo, V. Y., Cao, B., Wu, X., Lee, J. J. W., & Zee, B. C.-Y. (2016) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2016.03.009 · Cited by 70
Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High-Density Lipoprotein
Niesor, E. J., Schwartz, G. G., Perez, A., Stauffer, A., Durrwell, A., Suchánková, G., Benghozi, R., Abt, M., & Kallend, D. G. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6570-0 · Cited by 70
Future of Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Pharmacological Perspective
Mohammadpour, A. H., & Akhlaghi, F. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0071-8 · Cited by 70
CTRP12 ameliorates atherosclerosis by promoting cholesterol efflux and inhibiting inflammatory response via the miR-155-5p/LXRα pathway
Wang, G., Chen, J., Deng, W., Ren, K., Yin, S.-H., & Yu, X.-H. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03544-8 · Cited by 69

Authors: Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A.
Affiliations: National Institutes of Health (US)
ORCID: Probstfield, J L
Neaton, J D
Knoke, J D
Jacobs, D R
Bangdiwala, S
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1989-01
Volume: 79
Issue: 1
Pages: 8-15
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.79.1.8
OpenAlex: W2077760013
Cited by: 3,162
References: 27
Citations by year: 2026: 35 · 2025: 41 · 2024: 62 · 2023: 69 · 2022: 90 · 2021: 90 · 2020: 90 · 2019: 84 · 2018: 96 · 2017: 87 · 2016: 81 · 2015: 125 · 2014: 137 · 2013: 125 · 2012: 129
FWCI: 61.95
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hv012156-034)
National Heart, Lung, and Blood Institute (N01-HV32961, N01-HV 12156, N01-HV 12159)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: HDL cholesterol, coronary artery disease, cardiovascular mortality, inverse association, Framingham Heart Study, Multiple Risk Factor Intervention Trial, British Regional Heart Study, cardiovascular risk, sex differences
MeSH terms: Adult, Aged, Cardiovascular Diseases, Clinical Trials as Topic, Female, Humans, Cholesterol, HDL, Male, Middle Aged, Prospective Studies, Regression Analysis, Risk Factors, Sex Factors, Statistics as Topic, Cohort Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks